Trade BMY anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Bristol-Myers Squibb Co. (BMY) is trading at US$66.58, down 0.55% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$136.88B. Over the past 52 weeks, BMY has traded between US$42.52 and US$68.64. On Syfe you can trade BMY with $0 commission and add it to your watchlist.
| Previous close | US$66.95 |
|---|---|
| Market cap | US$136.88B |
| P/E ratio | 9.97 |
| 52-week range | US$42.52 – US$68.64 |
| Dividend yield | 3.77% |
| Volume | 5.54M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bristol-Myers Squibb Co.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Year: 1952
Bristol-Myers Squibb Co. (BMY) stock is trading at US$66.58, -0.55% from the previous close of US$66.95.
The market cap for Bristol-Myers Squibb Co. (BMY) stock is approximately US$136.88B.
The price-to-earnings ratio for Bristol-Myers Squibb Co. (BMY) is 9.97, based on the latest reported earnings.
The 52-week high for Bristol-Myers Squibb Co. (BMY) stock is US$68.64.
The 52-week low for Bristol-Myers Squibb Co. (BMY) stock is US$42.52.
Yes, Bristol-Myers Squibb Co. (BMY) pays a dividend. The trailing 12-month dividend yield is 3.77%.
Stay on top of BMY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
